
FDA moves to review allowing pharmacies to make BPC-157, TB-500, KPV
The agency is set to revisit peptide production, but evidence and safety data remain thin.

Curating from trusted global sources…
Curated from trusted global sources, refined into briefing-grade analysis with executive summaries, insights, and bullet-point takeaways.

The agency is set to revisit peptide production, but evidence and safety data remain thin.
A new arXiv paper points to an early “red and dead” galaxy transitioning by losing the fuel for star formation.

NASA’s rover detected the shallowest organic detection yet on Martian surface, but the origin remains uncertain.

A nearby super-Earth shrinks in the math, landing it in the habitable zone with better odds for a real atmosphere.
A frozen mummy just turned into a microbial time capsule, with implications for how boards think about bio assets and IP.

NASA’s Moon and Mars simulation in two habitats tests safety readiness, but also raises tough questions about freedom and continuity.
Genomic tools can reshape ecosystems fast, but calls are growing to ensure Indigenous communities lead on data rights and governance.
A field guide to oddball survival designs, and why decision-makers should care about what gets copied.
Executives need to track how generative AI and physics-based design may speed discovery and cut the long tail of resistance.

A peatland restoration push shows how bog management can translate childhood science into measurable climate impact.
A new Science Translational Medicine study builds “on-demand” CRISPR control, aiming to keep editing quiet until dosing.
Two different label-poster nudges shifted choices, and combining both produced the highest share of higher-welfare products.